Maternal HIV Disclosure to School Children: RCT of Family-based Intervention (Amagugu)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by University of KwaZulu
Sponsor:
Information provided by (Responsible Party):
University of KwaZulu
ClinicalTrials.gov Identifier:
NCT01922882
First received: July 8, 2013
Last updated: February 19, 2014
Last verified: February 2014
  Purpose

The purpose of this trial is to test whether, compared to the normal Standard of Care at primary health care clinics, a home-based counseling intervention ( the 'Amagugu' Counseling Intervention), will increase the number of HIV-infected mothers who are able to disclose their own HIV status to their primary school-aged children. The investigators also wish to examine whether the intervention improves the quality of the maternal-child relationship, emotional and well-being of the child and social support.


Condition Intervention
HIV
Disclosure
Behavioral: Amagugu Counseling Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Maternal HIV Disclosure to School Children: RCT of Family-based Intervention (Amagugu)

Resource links provided by NLM:


Further study details as provided by University of KwaZulu:

Primary Outcome Measures:
  • Change in disclosure [ Time Frame: Baseline, 3 months, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measures the proportion of HIV-infected women in the intervention and control arms who, within 3, 6 and 9-months disclose their HIV status to their 6-9 year old HIV-uninfected child.


Secondary Outcome Measures:
  • Change in health promotion [ Time Frame: Baseline, 3 months, 6 months, 9 months post baseline ] [ Designated as safety issue: No ]
    Measures the proportion of HIV-infected women in the intervention and control arms who, within 3, 6 and 9-months take their child on a health promotion visit to a clinic.

  • Change in custody planning [ Time Frame: Baseline, 3 months, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measures the proportion of HIV-infected women in the intervention and control arms who, within 3, 6 and 9-months develop, together with their child, a clear custody care plan.

  • Change in maternal depression scores [ Time Frame: Baseline, 3 months, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measures changes in maternal depression scores using the Patient Health Questionnaire -PHQ-9.

  • Change in maternal anxiety scores [ Time Frame: Baseline, 3 months, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measures changes in maternal anxiety scores using the General Anxiety Questionnaire-GAD-7

  • Change in child mental health scores [ Time Frame: Baseline, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measures changes in child mental health using the Child Behaviour Check-list (CBCL).

  • Change in quality of the parent-child relationship [ Time Frame: Baseline, 3 months, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measure changes in the parent-child relationship using the Parenting Stress Index (SF36).

  • Change in the quality of family functioning [ Time Frame: Baseline, 3 months, 6 months and 9 month post baseline ] [ Designated as safety issue: No ]
    Measures changes in the quality of family support and family functioning using the Family Assessment Device (FAD)


Other Outcome Measures:
  • Change in health perceptions [ Time Frame: Baseline and 9 months post baseline ] [ Designated as safety issue: No ]
    Measure baseline health perceptions and changes in health perceptions at the study endpoint using the Medical Outcomes Study (MOS-36)


Estimated Enrollment: 600
Study Start Date: May 2013
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Amagugu Counseling Intervention

The 'Amagugu' intensive 6 session home-based intervention. All 6 visits will be undertaken by a lay counsellor over a period of 8-10 weeks. The intervention includes 3 stages linked to the outcomes of the intervention:

  • family engagement, personal preparation, disclosure practice using intervention materials
  • health promotion training and a mother-child visit
  • play-for-communication and custody care planning
Behavioral: Amagugu Counseling Intervention
6-session home-based counseling intervention delivered by lay counselors at mothers' homes
No Intervention: Standard of Care

There is currently no Standard of Care in the South African DoH addressing the issue of parental disclosure of HIV status to HIV-uninfected children, beyond a recommendation to 'counsel to disclose'.

Therefore, for women who are randomized to the control group, we will ensure a Standard of Care for all mothers including a one-hour counselling session, focused specifically on disclosure, delivered at the primary health care facility as part of the HIV Programme.

We will orientate all health professionals in the enrolment clinic, including nurses, counsellors and community health care workers, on parental HIV disclosure, and provide a one-day training workshop (including training manual, role-plays and competency testing.


  Hide Detailed Description

Detailed Description:

Research aim

The primary aim of this clinical trial is to test the efficacy of an intervention which aims to increase rates of maternal HIV disclosure to HIV-uninfected children aged 6-9 years.

Secondary aims include to improve:

  1. health promotion and custody planning for mothers and their children;
  2. maternal and child mental health;
  3. family functioning and the quality of mother-child relationship;

Hypothesis

We hypothesize that our intensive home-based intervention (the 'Amagugu' Counseling Intervention), compared to the Standard of Care in clinic facilities, will significantly increase rates of maternal HIV disclosure and will result in improvements in the quality of the maternal-child relationship, emotional well-being of children and family support.

Research design

The intervention package was successfully piloted in late 2010 (Rochat et al 2013, BMC Public Health) and a large scale feasibility and acceptability field test was completed with 281 families in April 2012 funded by the Canadian International Development Agency. Preliminary results show that the intervention is highly acceptable, with more than 90% of mothers agreeing to participate; and effective with more than 90% having disclosed to their child either 'fully' (using the words 'HIV' and explaining that they have HIV) or 'partially' (using the word 'virus' and explaining that they have this virus).

Sample size calculation

Based on our pilot work we have shown that at least 60% of mothers disclosed their HIV status fully during the intervention. However, our results also show that prior disclosure to a current partner at baseline significantly increases the odds of full disclosure to children following the intervention. Since women enrolled in this trial will already be in HIV care they are likely to have received counseling and support to disclose their HIV status to their partners. To allow for the possibility of this effect in both intervention and control arms, we have powered the study conservatively to ensure that we have adequate power to detect differences between the groups. We have assumed that 30% women in the control arm will disclose their HIV status to their children in this trial and that the intervention will increase the proportion disclosing their HIV status to their children by at least 15 percentage points. Allowing for a loss-to-follow-up of 20%, 300 mothers in the intervention arm and 300 in the control arm will provide >90% power to detect a difference of 30% versus 45% (alpha type-one error of 5%, two-tailed) in HIV disclosure to children. This design will also provide adequate power for our main secondary outcome which is children's social and emotional wellbeing measured by the Child Behavior Checklist (Achenbach & Ruffle, 2000) as described in the objectives above. In high risk populations of children, one would expect the mean CBCL total score to be 50 for boys and for girls, with a standard deviation of 10. We hypothesize that our intervention would decrease the CBCL total difficulties score by at least 3 points whilst there would be no change in the CBCL score in the control group. With 300 women in each group we would have >90% power to detect a difference of 3 points between control and intervention.

Research methodology

The research site

The proposed research will be managed from the Wellcome Trust-funded Africa Centre. Recruitment will take place at a primary health care clinic located 1 km from the Africa Centre headquarters. Participants will be enrolled from an established HIV Programme, including (i) pre-ART patients who attend clinics on a 6-monthly basis to assess eligibility for ART based on immunological (CD4 cell count) and clinical staging and (ii) patients already on ART. Recruitment will be monitored carefully and if numbers are not sufficient we will seek ethics permission to expand to additional clinics.

Assessment schedule

All 600 mothers (i.e. 300 in the intervention and 300 in the Standard of Care arms) will receive assessments at four time points: at enrollment by the CRA and at home by one study interviewer as follows:

Time point 1: Baseline assessment at enrollment at clinic (CRA) Time point 2: 3-month assessment at home (study interviewer) Time point 3: 6-month assessment at home (study interviewer) Time point 4: 9-month assessment at home (study interviewer)

All assessments will be conducted in isiZulu and the study interviewer will be blinded to whether the mothers are randomized to the intervention or Standard of Care.

Data collection

Data collection will be completed using mobile phones that will digitally capture and transmit data from the field sites (clinic and women's homes) to the Africa Centre. Using the key pad the research staff will load a mobile researcher application on the phone which will display the questionnaires and assessments to be completed. On completion of the questions and assessments, the answers will be stored securely on the handsets until the phone is in the range of a mobile phone signal tower. There is a signal tower situated adjacent to the Africa Centre, and signal strength in the area of the proposed research clinic is generally excellent. When in range, the phones will automatically and securely upload the data to the central database.

Whilst the main data capture method will be the mobile phones, paper forms will be used for (i) informed consent, (ii) participant tracking information. These forms will be transported weekly from the clinic to the Africa Centre and stored in a secure Data Centre.

The Africa Centre has Standard Operating Procedures in place to track forms between the field, clinics and Centre, with clear documentation to identify 'chains of custody' as forms are handed between staff. In addition, a book containing a list of participating mothers and their unique study ID will be kept in a locked cabinet in the clinic; this will only be accessible by study staff. All files and data in the clinic are treated with the strictest of confident. The two paper forms and this book will be the only places where an individual's personal details are linked to their unique study ID.

Data management

Following uploading, data will be checked for completeness and accuracy the following day by the study coordinator; with queries returned to the field staff within 48 hours for correction.

Data cleaning will occur fortnightly, with routine checks for inaccuracies, outlying values and missing data, with immediate feed-back to the field team for rectification.

Data analysis

An intention-to-treat analysis, based on the randomization, will be used for the primary trial outcome - proportion of HIV-infected women who disclose to their HIV-uninfected child at 3, 6 and 9-months.

Because of the possibility that the randomization may lead to some imbalance in the distribution of risk factors across the trial arms, an assessment for baseline characteristics known to be associated with disclosure will be undertaken using binary logistic regression. These include age and gender of the child, mother's age, marital status and family composition, mother's health status, and educational attainment that will be collected as part of the study.

We will report both adjusted and unadjusted effects of the intervention on disclosure. The outcomes related to taking children on a health promotion visit to the clinic and developing a clear custody care plan will be analyzed using the same methodology.

The Child Behavior Check List (CBCL) scale is a multi-axial, empirically-based measure for assessing children's mental health and behavior by parent report. It consists of 120 items, measuring eight constructs or syndromes ( Withdrawn, Somatic complaints, Anxious/Depressed, Social Problems, Thought Problems, Attention Problems, Delinquent behavior, Aggressive behavior) and allowing for examination of two broad grouping of syndromes: Internalizing and Externalizing problems.

Raw scores can be converted to T scores to facilitate comparisons across the sub-scales, computing a Total Internalizing, Externalizing and Competence Score as well as a Total score. T scores from 50 to 70 are based on percentiles from normative samples of non- referred children. For statistical analysis of syndrome scales in this research, raw scale scores will be used and not T scores, in order to take account of the full range of variation in the scales. Scores will be standardized taking age and gender into account.

The CBCL has been cross-culturally validated, and translated for use in this research community and was used as a measure in the preliminary work by the applicants. In line with normative research we expect a mean of 50 and a standard deviation of 10. The analysis to compare changes in emotional and behavioral difficulties in children using the CBCL scale will be performed on an intention-to-treat analysis. Baseline comparability across the trial arms using the CBCL subscales will be assessed in subjects to address comparability by randomization assignment.

The statistical significance of changes in total CBCL scores from baseline to 9-month follow-up, within the control and intervention groups separately, will be calculated using t tests for normally distributed outcome measures. If baseline disparities across treatment arms are identified, then we will also perform linear regression analysis to allow adjustment for baseline disparities.

Data safety and monitoring plan

The quality of data collection and management will be monitored throughout the trial.

The use of mobile technology will result in several advantages in terms of data quality and management including: built in algorithms and skip patterns to ensure data are collected with accuracy, consistency and integrity; and 'real time' transmission of data collected in the field to the Africa Centre Data Centre, ensuring rapid data cleaning.

A Data Safety and Monitoring Board has been established and the terms of reference agreed.

  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Mother tested HIV-positive at least 6 months prior to the enrolment date
  • Mother has initiated HIV treatment or is established in pre-ART care
  • Mother has an HIV-uninfected child aged 6-9 years resident in her home
  • Mother has not yet disclosed to this child or other children in the household under 9 years of age
  • Mother has the physical and mental capacity for participation as assessed by the Clinic Research Assistant and Department of Health Staff

Exclusion Criteria:

  • Mother received her HIV-positive result less than 6 months ago
  • Mother has not yet undergone or received results of her first CD4 test to confirm pre-ART status
  • Mother does not have an HIV-uninfected child or other children under the age of 9 years resident in the home
  • Mother has previously participated in the Amagugu intervention
  • Mother is resident in the home, but migrates for work on more than five consecutive days of each week
  • Mother is identified as psychotic or delusional based on the study staffs' judgement, or is unable to give signed informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01922882

Contacts
Contact: Tamsen J Rochat, PhD +27355507500 trochat@africacentre.ac.za
Contact: Suzette Grobler +27355507500 sgrobler@africacentre.ac.za

Locations
South Africa
Africa Centre for Health and Population Studies Recruiting
Somkele, KwaZulu-Natal, South Africa, 3935
Principal Investigator: Tamsen J Rochat, PhD         
Principal Investigator: Ruth M Bland, MD         
Sponsors and Collaborators
University of KwaZulu
Investigators
Principal Investigator: Ruth M Bland, MD Africa Centre for Health and Population Studies, University of KwaZulu-Natal
Principal Investigator: Tamsen J Rochat, PhD Africa Centre for Health and Population Studies, University of KwaZulu-Natal
  More Information

Additional Information:
Publications:
Responsible Party: University of KwaZulu
ClinicalTrials.gov Identifier: NCT01922882     History of Changes
Other Study ID Numbers: 1R01HD074267-01
Study First Received: July 8, 2013
Last Updated: February 19, 2014
Health Authority: South Africa: Department of Health

Keywords provided by University of KwaZulu:
HIV
Maternal disclosure
Health promotion
Maternal mental health
Child behavior

ClinicalTrials.gov processed this record on August 28, 2014